Article Text

other Versions

PDF
A novel tetravalent Leptospira bacterin protects against infection and shedding following challenge in dogs
  1. H. L. B. M. Klaasen, PhD DVM
  1. Department of Microbiological R&D, MSD Animal Health, Wim de Körverstraat 35, Boxmeer 5831 AN, The Netherlands
  1. M. van der Veen, BSc
  1. Department of Microbiological R&D, MSD Animal Health, Wim de Körverstraat 35, Boxmeer 5831 AN, The Netherlands
  1. M. J. C. H. Molkenboer, BSc
  1. Department of Global Regulatory Affairs Immunologicals, MSD Animal Health, Boxmeer 5831 AN, The Netherlands
  1. D. Sutton, BVetMed, MRCVS
  1. Global Marketing Department, Merck Animal Health, Milton Keynes, Buckinghamshire, UK
  1. E-mail for correspondence: eric.klaasen{at}merck.com

Abstract

Recent evidence based on the current epidemiological situation suggests that vaccines against canine leptospirosis in Europe should be directed against infection with Leptospira interrogans (sensu lato) serogroups Canicola, Icterohaemorrhagiae, Grippotyphosa and Australis. In the eight studies presented here, dogs were vaccinated with Nobivac L4 (MSD Animal Health), a new tetravalent inactivated vaccine containing antigen from four strains representing these four serogroups. The dogs were then challenged, together with unvaccinated control dogs, using heterologous strains from the same four serogroups. In four of the studies, pups without agglutinating antibodies against the four serogroups were vaccinated with Nobivac L4 vaccine. In a further four studies, Nobivac L4 vaccine was given 48 hours after administration of antiserum from vaccinated dogs designed to mimic the serological status of pups with maternally derived antibodies against these serogroups. In all eight studies, vaccine efficacy was assessed in terms of antibody response, clinical signs, fever, thrombocyte count, frequency of positive isolation of challenge organisms from blood, urine and kidney and frequency of interstitial nephritis. The results demonstrate that Nobivac L4 vaccine induces sterile immunity against leptospiraemia and renal infection with strains of serogroups Canicola, Icterohaemorrhagiae and Grippotyphosa, and induces sterile immunity against leptospiraemia with a strain of serogroup Australis. Since sterile immunity was achieved in pups pretreated with antiserum as well, it can be concluded that this vaccine is also likely to be efficacious in the face of maternally derived antibodies in pups from the age of six weeks.

  • Leptospira
  • Vaccines
  • Dogs
  • Zoonoses
  • Accepted October 23, 2012.

Statistics from Altmetric.com

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.